Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.
Weight Loss· Editorial-reviewed against primary sources

How Much Weight Can You Lose in a Month on a GLP-1? Realistic Numbers

A safe pace is about 1 to 2 pounds a week, and month one on a GLP-1 is usually the slowest because the dose is still low. Here is what the trials actually show, why fast loss is mostly water, and whether losing 10 pounds in a month is realistic.

By WeighedHealth Editorial

5 min readUpdated

0–2 lb/week
Pace the CDC considers safe and sustainable for weight loss
0–5 lb
Typical first-month loss on a GLP-1 starting dose
0.0%
Average body-weight loss on semaglutide over 68 weeks (STEP-1)
~0%
Average loss on top-dose tirzepatide over 72 weeks (SURMOUNT-1)

The short version

Most people lose roughly 2 to 5 pounds in their first month on a GLP-1, not the dramatic drop the before-and-after photos suggest. The reason is simple: month one is a starting dose, deliberately low to protect your stomach, so the appetite effect is only partway switched on. The big trial curves show weight coming off steadily for months, with the fastest fat loss usually landing between months two and nine, not in week four [2][3].

Losing 10 pounds in a single month is possible for some people, especially those starting at a higher body weight, but it is not the expected result and much of any very fast early loss is water, not fat. A gradual pace of about 1 to 2 pounds per week is the rate health agencies consider safe and sustainable [1].

What the safe general rate actually is

The CDC's guidance is unambiguous: people who lose weight at a gradual, steady pace of about 1 to 2 pounds a week are more likely to keep it off than people who drop it faster [1]. Over a month that is roughly 4 to 8 pounds. That range predates GLP-1 medications and still applies to them, because the goal of these drugs is durable fat loss, not a fast number on the scale.

GLP-1 medications do not override that biology. They make the safe rate easier to hit by reducing appetite and slowing gastric emptying, so you eat less without white-knuckling it. But a healthy pace is still a pace measured in months. Anyone promising 15 or 20 pounds in your first four weeks is describing water shifts and glycogen depletion, not sustainable fat reduction.

Why month one is the slowest month

Every GLP-1 uses dose titration: you start low and step up every four weeks. Semaglutide (Wegovy) begins at 0.25 mg weekly, a dose chosen to limit nausea, not to maximize weight loss. Tirzepatide (Zepbound) starts at 2.5 mg for the same reason. At these opening doses the appetite-suppressing effect is only partly present, so month-one loss is modest by design.

This trips up a lot of new patients. They expect the fireworks in week one and get discouraged by a 2 or 3 pound change. But the starting dose is a ramp, not the destination. The dose that actually drives most of the weight loss, 2.4 mg for semaglutide or 10 to 15 mg for tirzepatide, is still two to four months away when you begin. Judging the medication by month one is like judging a marathon by the first half mile.

Water weight versus fat

When people do see a big scale drop in the first week or two, most of it is not fat. Cutting calories and carbohydrates depletes glycogen, and every gram of stored glycogen holds about three to four grams of water. Losing those stores can shed several pounds fast, which is why low-carb and very-low-calorie diets show impressive week-one numbers that stall almost immediately.

Fat loss is slower and steadier. One pound of body fat stores roughly 3,500 calories, so even a solid daily deficit of 500 calories produces about a pound of fat loss per week. That math does not change on a GLP-1. What changes is how achievable the deficit becomes, because the medication blunts hunger and cravings instead of leaving you to fight them. The scale reflects fat plus water plus food in transit, so day-to-day it bounces; the monthly trend is the signal.

A grounded month-by-month picture

Here is a realistic arc for someone tolerating the medication well. Month one, on the starting dose, often brings 2 to 5 pounds, some of it water. Months two and three, as the dose steps up, weekly loss frequently settles into the 1 to 2 pound range and the trend becomes clear. Months four through nine are usually the steepest part of the curve, when appetite suppression is fully in effect at the therapeutic dose.

The pivotal trials show where this leads. In STEP-1, adults on semaglutide 2.4 mg lost an average of 14.9 percent of body weight over 68 weeks [2]. In SURMOUNT-1, tirzepatide at its highest dose produced about a 21 percent average loss over 72 weeks [3]. Both curves decline gradually and only start to flatten near the end. For a 220-pound person, 15 percent is about 33 pounds and 21 percent is about 46 pounds, spread across more than a year, not a month.

Why chasing very fast loss backfires

Pushing the scale down as fast as possible carries two specific costs. The first is muscle. When you lose weight quickly, a meaningful share of the loss can come from lean tissue rather than fat, especially if protein intake and resistance training are neglected, and lower muscle mass lowers resting metabolism. This is well documented with GLP-1 medications and is the main argument for prioritizing protein and strength work while you lose.

The second is gallstones. The NIDDK warns that losing weight very quickly raises the chance of forming gallstones, because rapid loss changes bile composition and can keep the gallbladder from emptying properly [4]. Gallbladder problems are a recognized adverse event across GLP-1 trials. Both risks point the same direction: a steady pace is not just easier to sustain, it is safer for your body composition and your gallbladder.

So can you lose 10 pounds in a month?

Sometimes, yes, but it should not be the target. People starting at a higher weight lose more in absolute pounds early on, and a heavier person may see 8 to 10 pounds in month one where a lighter person sees 3 to 4. Some of that gap is water. If you hit 10 pounds in a month and feel well, that is fine. Engineering it through crash dieting on top of the medication is where trouble starts.

A better yardstick than a monthly pound target is the trend over 12 weeks. If your weight is drifting down and your appetite is genuinely lower as the dose climbs, the medication is working, even if any single month looks unremarkable. The trials that produced 15 to 21 percent loss did it one modest month at a time [2][3]. Patience is not a consolation prize here; it is how the results actually happen.

Sources

Primary sources cited above. FDA labeling, peer-reviewed trials, and specialty-society guidelines only.

  1. Steps for Losing Weight — Healthy Weight and Growth · Centers for Disease Control and Prevention (CDC), 2024
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine, 2021 · PMID 33567185
  3. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) · New England Journal of Medicine, 2022 · PMID 35658024
  4. Dieting & Gallstones · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 2017

People also ask

  • How much weight will I lose in the first month on Wegovy or Zepbound?

    For most people, roughly 2 to 5 pounds in month one, with some of that being water rather than fat. The first month is spent on the lowest starting dose (0.25 mg for semaglutide, 2.5 mg for tirzepatide), which is chosen to limit nausea rather than to maximize weight loss. The appetite-suppressing effect is only partly active at that dose. Heavier starting weights tend to show larger early drops. If your month-one number looks small, that is expected; the dose that drives most weight loss is still two to four months away.

  • Is it possible to lose 10 pounds in a month on a GLP-1?

    It happens for some people, especially those starting at a higher body weight, but it is not the expected or recommended target. Part of any very fast early loss is water from glycogen depletion, not fat. Fat loss is capped by biology: a 500-calorie daily deficit yields about one pound of fat per week, or roughly four pounds a month. If you reach 10 pounds and feel well, that is fine, but forcing it with crash dieting on top of the medication raises the risk of muscle loss and gallstones. Judge progress over 12 weeks, not one month.

  • Why am I not losing weight in my first month?

    The most common reason is that you are still on the starting dose, which is deliberately low. GLP-1 medications titrate up every four weeks, and the appetite effect strengthens as the dose climbs. A modest or flat month one does not mean the drug is failing. Other factors include water retention, glycogen shifts, changes in sodium or carbohydrate intake, and normal day-to-day scale fluctuation. Track the trend across several weeks rather than reacting to single weigh-ins. If weight has not moved at all by the time you reach a therapeutic dose, that is worth discussing with your prescriber.

  • What is a safe rate of weight loss?

    The CDC's guidance is about 1 to 2 pounds per week, which works out to roughly 4 to 8 pounds a month. People who lose at this gradual, steady pace are more likely to keep the weight off than people who lose it faster. This range applies to GLP-1 medications too. The drugs make the safe rate easier to reach by lowering appetite, but they do not make faster loss inherently better. Very rapid loss increases the share that comes from muscle and raises the risk of gallstones, so a steady pace is both more sustainable and safer.

  • How much of early GLP-1 weight loss is water versus fat?

    In the first week or two, a large share of any big scale drop is water, not fat. Cutting calories and carbohydrates depletes glycogen, and each gram of stored glycogen holds three to four grams of water, so glycogen loss releases several pounds quickly. That is why low-carb and very-low-calorie approaches show fast week-one numbers that then stall. True fat loss is slower and steadier, roughly a pound per week per 500-calorie daily deficit. Over a full month the water effect fades and the trend reflects mostly fat, which is why the monthly average is more meaningful than any single day.

  • When do GLP-1 medications work best for weight loss?

    The steepest part of the weight-loss curve usually falls between months two and nine, once you have titrated up to a therapeutic dose. Month one is typically the slowest because the dose is still low. In STEP-1, semaglutide produced an average 14.9 percent loss over 68 weeks, and in SURMOUNT-1 top-dose tirzepatide reached about 21 percent over 72 weeks. Both curves decline gradually and only flatten near the end. The practical takeaway: expect a long, steady descent rather than a fast early drop, and give the medication several months at full dose before judging results.

  • Does losing weight too fast cause muscle loss?

    It can. When weight comes off quickly, a meaningful portion can be lean tissue rather than fat, particularly if protein intake is low and you are not doing resistance training. This matters because muscle drives resting metabolism, so losing it can make maintaining your new weight harder later. GLP-1 medications do not exempt you from this. The standard countermeasures are eating adequate protein, typically weighted toward each meal, and doing strength training two or more times a week while you lose. A steadier pace also preserves more muscle than a crash approach.

  • Can rapid weight loss cause gallstones?

    Yes. The NIDDK warns that losing weight very quickly raises the chance of forming gallstones. Rapid loss changes bile composition, prompting the liver to release extra cholesterol into bile, and can prevent the gallbladder from emptying properly. Gallbladder-related events are a recognized side effect across GLP-1 obesity trials. This is one of the concrete reasons a gradual pace of about 1 to 2 pounds per week is recommended over aggressive, fast loss. If you develop upper-right abdominal pain, especially after meals, that warrants prompt medical attention.

Related reads

Share: